Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.
暂无分享,去创建一个
[1] D. Hopwood,et al. Abnormal expression of growth regulatory factors in Barrett's oesophagus. , 1991, Clinical science.
[2] J. Bartek,et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. , 1991, Oncogene.
[3] W. Gullick,et al. c‐erbB‐2 proto‐oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival material , 1991, International journal of cancer.
[4] Takuma Sasaki,et al. Expression of C‐erbB‐2 oncoprotein in gastric carcinoma. Immunoreactivity for C‐erbB‐2 protein is an independent indicator of poor short‐term prognosis in patients with gastric carcinoma , 1991, Cancer.
[5] R. Baserga,et al. Growth regulation of the PCNA gene. , 1991, Journal of cell science.
[6] S. Shousha,et al. c-erbB-2 expression in different histological types of invasive breast carcinoma. , 1991, Journal of clinical pathology.
[7] E. Appella,et al. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Kung,et al. Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] R Montesano,et al. Frequent mutation of the p53 gene in human esophageal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] W. Gullick,et al. c‐erbB‐2 oncogene expression in ovarian cancer , 1990, The Journal of pathology.
[11] W. Bodmer,et al. p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] B. Vogelstein,et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. , 1990, Science.
[13] P. D. Boyrer. In reply: the overhead question. , 1990, Science.
[14] K. Sikora. The Molecules of Cancer , 1990, Journal of the Royal College of Physicians of London.
[15] N. Lemoine,et al. The c‐erbB‐2 proto‐oncogene in human pancreatic cancer , 1990, The Journal of pathology.
[16] Kazuhiro Yoshida,et al. pp60c‐src protein kinase activity in human gastric carcinomas , 1990, International journal of cancer.
[17] K. Sikora. Cancer genes in gastrointestinal malignancy. , 1990, Bailliere's clinical gastroenterology.
[18] M. Weber,et al. Inhibition of epidermal growth factor receptor biosynthesis caused by the src oncogene product, pp60v-src , 1990, Molecular and cellular biology.
[19] S. Meltzer,et al. Tissue-specific expression of c-Ha-ras in premalignant gastrointestinal mucosae. , 1989, Experimental and molecular pathology.
[20] T. Ravikumar,et al. Ras gene activation and epidermal growth factor receptor expression in human colon cancer. , 1989, The Journal of surgical research.
[21] D. Spandidos,et al. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa. , 1989, Anticancer research.
[22] W. Gullick,et al. c‐erbB‐2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study , 1989, The Journal of pathology.
[23] N. Benvenisty. A Molecular View of Tissue Differentiation and Development , 1989, Journal of the Royal College of Physicians of London.
[24] J. Varley,et al. An immunohistochemical and in situ hybridization study of c‐myc and c‐erbB‐2 expression in primary human breast carcinomas , 1989, The Journal of pathology.
[25] A. Tigges,et al. Expression of the nuclear oncogene p53 in colon tumours , 1989, The Journal of pathology.
[26] D. Spandidos,et al. Oncogenes and onco‐suppressor genes: Their involvement in cancer , 1989, The Journal of pathology.
[27] D. Nathans,et al. Induction of protooncogene c-jun by serum growth factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Walker,et al. p21 ras protein expression in benign and malignant , 1988, The Journal of pathology.
[29] M. Lavin,et al. Immunocytochemical demonstration of p21ras in normal and transitional cell carcinoma urothelium , 1988, The Journal of pathology.
[30] M. Yaniv,et al. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts , 1988, Nature.
[31] N. Nomura,et al. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. , 1988, Oncogene.
[32] A. Ochiai,et al. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. , 1987, Japanese journal of cancer research : Gann.
[33] D. Ransohoff,et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.
[34] D. F. Petersen,et al. Cell growth and division. II. Experimental studies of cell volume distributions in mammalian suspension cultures. , 1967, Biophysical journal.
[35] L. Bonelli. Adenocarcinoma in Barrett's oesophagus. I: , 1993 .
[36] D. Hopwood,et al. Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases. , 1993, Digestive diseases.
[37] W. Gullick,et al. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. , 1991, British medical bulletin.
[38] N. Kamada,et al. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. , 1991, Cancer research.
[39] D. Lane,et al. p53: oncogene or anti-oncogene? , 1990, Genes & development.
[40] T. Graf,et al. Relationships Between Oncogenes and Growth Control , 1990 .
[41] R. D. Cohen. The metabolic and molecular basis of acquired disease , 1990 .
[42] S. N. Fedorov,et al. [Proto-oncogene expression in human carcinomas of the stomach and in the gastric mucosa of rats exposed to N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis]. , 1989, Eksperimental'naia onkologiia.
[43] Fedorov Sn,et al. [Proto-oncogene expression in human carcinomas of the stomach and in the gastric mucosa of rats exposed to N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis]. , 1989 .
[44] H. Ikeda,et al. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. , 1988, Cancer detection and prevention.
[45] D. Wheatley,et al. Cell growth and division , 1982 .
[46] M. Hollstein,et al. Frequent mutation of the p 53 gene in human esophageal cancer ( tumor suppressor gene / DNA sequence analysis / nitrosamines ) , 2022 .